Adtalem Global Education Inc. (ATGE)

Consumer Defensive
Education & Training Services
United States
Yahoo Finance  •  Trading View  •  Company site
Price
$95.11
▼ -5.73 (-5.68%)
Market Cap
$3,455,208,192
Shares: 35,689,719.626
P/E
N/A
P/B: N/A
ROE
5.54%
Current Ratio: 0.68
Fundamentals Score
55 (NEUTRAL)

Company Overview

Adtalem Global Education Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

Headquarters: 233 South Wacker Drive, Chicago, IL, 60606, United States  |  Employees: 4703  |  Website: covista.com
Key Contacts
IR / Phone: 312 651 1400
Exchange: NYQ
Industry: Education & Training Services
Quick Financial Snapshot
Revenue$503,385,000
Net Income$76,376,000
Free Cash Flow$10,121,000
Book Value / ShareN/A

Balance Sheet & Liquidity

Total Liabilities$1,235,917,000
Total Equity$1,378,796,000
Debt / EquityN/A
Current Ratio0.68
Interest CoverageN/A
Working CapitalN/A

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)N/A
Industry P/EN/A
Forward P/E10.57
P/BN/A
Price / SalesN/A
P / FCFN/A
EV / EBITDAN/A
Graham NumberN/A
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin 59.19%
Operating Margin N/A
Net Margin N/A
ROIC N/A
Asset Turnover N/A

Automated Fundamental Signals (Score: 55)

Passed
  • EPS shows upward trend
  • Price CAGR 12.45%
  • Gross Margin 59.2%
  • Debt/Equity ratio
  • Operating Margin 22.1%
  • Positive Free Cash Flow
Failed
  • EPS CAGR 1.33%
  • CapEx intensity
  • Current Ratio
  • Debt/EBITDA
  • DCF valuation (Overvalued)

Price Chart (Candlestick)

Technical Analysis (Score: 50)

RSI (14)31.88
SMA 50105.21
SMA 200120.48
MACD-2.71
Signal NEUTRAL
RSI 31.9, SMA trend bearish, momentum -10.6%.

Governance & Management

Governance scores: Audit: 1 | Board: 4 | Compensation: 7 | Shareholder Rights: 1
Executive Team
NameTitle
Mr. Stephen W. Beard J.D. CEO & Chairman (1971)
Mr. Robert J. Phelan CPA Senior VP & CFO (1965)
Mr. Douglas G. Beck J.D. Senior VP of Institutional Support Services, General Counsel & Corporate Secretary (1967)
Mr. Scott Day Liles President of Adtalem Medical & Veterinary (1966)
Mr. Michael Betz Chief Digital Officer & President of Walden University (1973)
Mr. Manjunath Gangadharan VP & Chief Accounting Officer (1983)
Mr. Jonathan Spitzer C.F.A. Vice President of Investor Relations (—)
Mr. Maurice Herrera Senior VP & Chief Marketing Officer (1970)
Governance data last updated: 2/1/2026

Latest News

No news available for this company.

← Back